Trastuzumab botidotin has met the primary endpoints of its pivotal Phase 2 trial for 3L+ advanced HER2+ BC based on results from the primary analysis, which the Company used to submit an NDA to the ...

The Labour manifesto pledged to “maximise our potential to lead the world in clinical trials”. With our regulatory advantage ...

The legislation will make it easier for hospitals to make improvements and harder for UMMC to open facilities outside of ...

Officials at ARM, ASGCT, and ISCT convened a small group of scientists, policy experts, religious leaders and patient ...

By Chioma Obinna Africa’s healthcare landscape is undergoing a rapid transformation, fueled by digital technologies that are ...

Key Highlights: <li /> Global first immuno + anti-vascular bispecific antibody approved: ivonescimab for EGFR-TKI resistant nsq-NSCLC.

Aptose Biosciences Inc. ("Aptose" or the "Company") , a clinical-stage precision oncology company developing a tuspetinib (TUS)-based triple drug frontline therapy to treat patients with newly ...

Bluesky was opening up to the public and was known as one of the many X competitors that emerged after Elon Musk acquired the ...

UVa Health and four other institutions have been selected to participate in a "mobile care collaborative" working to improve ...

LUND, Sweden, March 31, 2025 /PRNewswire/ -- Alfa Laval, Outokumpu and SSAB have entered into a strategic cross-industry collaboration ... part of the Laakso Joint Hospital project, a new hospital ...

In a significant move aimed at fostering innovation and technological advancement in healthcare, the Homi Bhabha Cancer Hospital and Research Centre (HBCH), Punjab, under the Department of Atomic ...